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It was recently reported that Duchenne muscular dystrophy 
(DMD) patients and mdx mice have elevated levels of caveo-
lin-3 expression in their skeletal muscles. However, it remains 
unknown whether this increased caveolin-3 levels contribute to 
the pathogenesis of DMD. Also mitochondrial DNA mutation 
in the tRNA methionin (tRNA Met) gene has been shown to 
be associated with muscle weakness, severe exercise intoler-
ance, lactic acidosis and growth retardation. Since DMD is X-
linked maternally inherited disease, mitochondrial mutation in 
tRNA(Met) gene can be suspected to be the cause for the inef-
ficient splicing of dystrophin gene during its expression and can 
be implicated as the cause of dystrophin inactive protein.
Results gave further proof to decreased expression of in-
ducible nitric oxide synthase (iNOS) mRNA, which leads to 
increased expression in caveolin 3 mRNA in lymphocytes of 
DMD  patients  compared  to  controls.  However  using  SSCP, 
there was no evidence for tRNA(Met) gene mutation among 
DMD patients, and only one patient presented a mutation in the 
caveolin gene compared to controls.
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Rehabilitation of the children with mental and physical dis-
orders for improvement of their adaptation to modern society is 
an actual medical and social problem.
Cooperative work of doctors, psychologists, teachers and 
parents of the pupils of special correctional school N° 81 in 
Moscow was approved by the Ethical Committee of medical and 
pharmaceutical universities. Forty-five pupils of primary school 
(range 8-12 years) with impaired intellectual development, cog-
nitive disorders, syndrome of hyperactivity and attention defi-
ciency were examined. All the children had the birth trauma in 
their history. Clinical neurological examination and palpation 
were conducted to identify the role of myotonic syndromes in 
the cranio-vertebral region and biomechanically significant dis-
turbances in the cervical spine that affect the cerebral blood flow. 
A neuropsychological study was used to examine the cognitive 
sphere and the state of brain activity. EEG-neurophysiological 
examination of children was carried out to assess the state of 
brain activity, the definition of cortical areas responsive to the 
effects of stress factors, as well as hemispheric interactions, as 
correlates of memory processes, learning, etc. The NEC-method 
was used to study the cerebral metabolism and adaptation possi-
bilities. Color duplex scanning (ultrasonic scanner Sono Scape 
1000) was conducted to identify hemodynamically significant 
tortuosity of the proximal extracranial parts of internal carotid 
and vertebral arteries. Tortuosities of the vessels slow down the 
circulation and lead to vertebro-basilar insufficiency in the cor-
responding cerebral region.
The  main  complains  observed  in  children  were  head-
ache, fatigue and meteopathies. Neuropsychological studies 
revealed disorders in the cognitive, personal, emotional and 
behavior status, as well as hyperactivity and diminished atten-
tion. Neurological examination revealed disturbances of mus-
cular coordination, muscular hypertension or hypotonia. The 
patho-biomechanical  changes  observed  were  rigidity  in  the 
shoulder girdle, shorten muscles of the neck and anterior part 
of the chest (syndrome of upper aperture), kyphosis, dysfunc-
tions of the pelvis, functional limb asymmetry and postural 
displacement.
EEG analysis revealed signs of functional immaturity of 
the cerebral cortex in the children. Manifestations of the weak-
ening of inter-hemispheric interactions were observed in 50% 
of cases.
According to the color duplex scanning, changes of the 
brachio-cephalic arteries were divided into three groups: 
1) hemodynamically significant (S-or C-shaped crimp of 
internal carotid arteries);
2) S-or C- shaped hemodynamically significant (misalign-
ment of the vertebral arteries in one or two sides); 
3) a combination of pathological tortuosity of the internal 
carotid and vertebral arteries.
Signs of hypoxia and intracranial venous hypertension oc-
curred in 65% of cases.
The  scientifically-based  comprehensive  neuro-rehabilita-
tion scheme was worked out during this pilot project in order to 
correct the myotonic syndrome in the neck, cranio-vertebral re-
gion, and to improve the cerebral metabolism and liquor dynam-
ics. We used biodynamic poly-receptor techniques, neuro-motor 
and respiratory gymnastics, aromatherapy and neuroprotectors, 
because we performed our treatment in school.
Conclusions.  Integrated  clinical  neurological,  neuropsy-
chological and instrumental studies of bioelectric activity, meta-
bolic processes of the brain and the state of the brachiocephalic 
arteries, allowed us to refine pathogenetic mechanisms of the 
consequences of birth trauma in children, myotonic neurovas-
cular and mental disorders included.
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Comprehensive neuro-rehabilitation of the children with 
mental problems improved their clinical and emotional back-
ground, memory and cognitive functions. EEG and NEC ex-
amination marked the trends in recovery of inter-hemispheric 
connections and in normalization of the bioelectrical activity in 
the brain.
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The objective to identify appropriate outcome measures 
to use in clinical trials or observational studies. Natural history 
data of patients with the heterogeneous juvenile/adult form of 
glycogen storage disease type II (GSDII) are useful to evaluate 
enzyme replacement therapy (ERT).
We evaluated several outcome measures before and during 
ERT, such as a series of timed and graded functional tests i.e. 
Gait, Stairs, Gowers, Chair (GSGC) score, the Six-Minute Walk 
Test (6MWT), Forced Vital Capacity.
During an observational study we monitored a series of 32 
patients using these outcome measures at 1 year after ERT and 
observed a partial but significant improvement. A significant 
decrease was observed in Gait time and time to raise from the 
chair and total GSGC score. A gain of function was observed 
in few cases.
Important, crucial topics seem to be: the use of different 
functional parameters in determining the efficacy of ERT, since 
not all juvenile/adult patients respond similarly, and, reliable 
outcomes of treatment.
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Laminopathies are a group of genetic diseases caused by 
mutations in the nuclear protein lamin A/C or in related pro-
teins. A group of laminopathies targets specific tissues – tissue-
specific laminopathies –, other laminopathies affect multiple 
tissues – systemic laminopathies.
The Italian Network for Laminopathies is  a group of 
Clinical and Research Centers performing clinical and molec-
ular diagnosis or biomedical research in the field of laminopa-
thies. Aims of the Italian Network for laminopathies are: to 
connect Italian Centers involved in diagnosis and biomedical 
research of laminopathies; provide information on the clini-
cal features of Laminopathies to family doctors, specialists 
and patients; provide the contact information of specialists 
involved  in the diagnosis and research of  laminopathies; 
provide updated information on biomedical research in the 
field of laminopathies; organize an Italian Registry for Lami-
nopathies containing clinical and biological data; establish a 
bank of biological material; report news on relevant events 
and meetings; report on funding opportunities in the field of 
Laminopathies research. 
The Italian Network for Laminopathies website provides 
updated  information  of  the  Network  and  of  Laminopathies-
related events.
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Myasthenia gravis (MG) is a heterogeneous disorder en-
compassing several subtypes. In our patients population, the 
most numerous and homogeneous group is represented by pa-
tients  with  a  late  onset,  seropositive,  non-thymomatous  MG 
(LO-Ab+noTh). We have analyzed the frequency of HLA-A, 
-B, - DRB1, -DQA1 and -DQB1 alleles in 81 unselected Italian 
MG patients and in 100 healthy controls. HLA allele frequencies 
were estimated by direct count and compared in a 2 × 2 contin-
gency table analysis using the Fisher exact test; p values were 
corrected for multiple comparisons according to the Bonferroni 
method (pc). When the entire MG population was considered, 
no association was found between the occurrence of the disease 
and the presence of any of the alleles analyzed. However, when 
the LO-Ab+noTh patients were compared to controls, a positive 
association of the DRB1*16 and the DQB1*0502 alleles was 
observed (pc 0,0211 and 0,00768 respectively). On the contra-
ry, the same association was not present in patients with either 
early-onset, seropositive, non-thymomatous MG, or with thy-
momatous MG. The association of DRB1*16 and DQB1*0502 
with MG has been previously reported in Italian patients with 
different features, but not in LO-Ab+noTh MG. According to 
these results, DRB1*16 and DQB1*05:02 might be considered 
as genetic markers of LO-Ab+noTh MG, while their role as pre-
disposing genetic factors for MG should be clarified by further 
investigations.